• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FIDIA FARMACEUTICI S.P.A. HYALURONIC ACID SODIUM HYALURONATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FIDIA FARMACEUTICI S.P.A. HYALURONIC ACID SODIUM HYALURONATE Back to Search Results
Catalog Number 89122-0724-20
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Embolism (1829); Muscle Weakness (1967); Nerve Damage (1979); Neuropathy (1983); Pain (1994); Skin Discoloration (2074); Vasodilatation (2127); Hypoesthesia (2352); Paresthesia (4421); Localized Skin Lesion (4542); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Event Description
This serious case was detected in the medical literature on 16-dec-2020 from "berríos-hernández, m. , casas-fernández, l. , blanco-rodríguez, j. And suárez-peñaranda, j. M. (2020), dermal embolization associated with peroneal mononeuropathy: an unusual complication after hyaluronic acid intra-articular injections. Int j dermatol. Https://doi. Org/10. 1111/ijd. 15347". This spontaneous case was reported in the medical literature by a physician from spain and concerns a (b)(6)-year-old female patient who developed therapeutic embolization, livedo reticularis, leg pain and peroneal nerve injury following intra-articular injection of hyaluronic acid for gonarthrosis. A (b)(6)-year-old woman with bilateral ga had been treated for the last 6 years with biannual intra-articular ha infiltrations. Injections were made using a lateral suprapatellar approach. With the patient supine and the knee extended, an 18-gauge needle was positioned perpendicular to the skin on the suprapatellar bursa 1 cm above the proximal patellar margin. Twenty-four hours after the last bilateral infiltration, she complained of intense pain on the proximal surface of her left leg. Physical examination revealed an extensive, livedoid, erythematous lesion with some nonpalpable, purpuric areas. The patient was treated symptomatically with nonsteroidal anti-inflammatory drugs (nsaids), but 1 week later, the lesion persisted with associated paresthesia on the lower third of the leg and distal strength loss. Electromyography confirmed a mononeuropathy of the left peroneal nerve, with decreased nerve excitability and sensorial response, and denervation of the dependent musculature. A punch biopsy was taken, and histopathological examination revealed slightly basophilic, amorphous, intraluminal material in some small vessels located in the subcutaneous fat tissue as well as in the surrounding interstitium. It stained with alcian blue, and it failed to show refringence under polarized light. Thrombosis or inflammatory signs were not noted. In addition, there was mild dilatation of the superficial dermal vessels, some showing telangiectatic appearance with minimal lymphoid infiltrate. Findings were considered consistent with ha embolism, and symptomatic treatment with nsaids was continued. After 7 months, skin lesions had almost completely disappeared and muscular function returned to normal. Only mild hypoesthesia on the involved area persisted for 10 months.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameHYALURONIC ACID
Type of DeviceSODIUM HYALURONATE
Manufacturer (Section D)
FIDIA FARMACEUTICI S.P.A.
via ponte della fabbrica, 3/a
abano terme 35031
Manufacturer (Section G)
FIDIA FARMACEUTICI S.P.A.
via ponte della fabbrica, 3/a
abano terme, pd 35031
IT 35031
Manufacturer Contact
giuseppe di sante
via ponte della fabbrica 3/a
abano terme, pd 35031
IT   35031
MDR Report Key11154384
MDR Text Key226292999
Report Number9610200-2021-00001
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)Y
Reporter Country CodeSP
PMA/PMN Number
P950027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation
Type of Report Initial,Followup
Report Date 03/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/12/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Catalogue Number89122-0724-20
Was Device Available for Evaluation? No Answer Provided
Is the Reporter a Health Professional? No
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received02/09/2021
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No Answer Provided
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 01/12/2021 Patient Sequence Number: 1
-
-